REPLY: Go Reply and Sprint Reply Automate the Creation of Clinical Study Reports for Dr. Willmar Schwabe with AI
Go Reply, a leading Google Cloud Premier Partner, together with Sprint Reply, the Reply Group’s expert in strategic consulting and digital transformation, has developed an AI-driven tool for the pharmaceutical company Dr. Willmar Schwabe that streamlines the preparation of clinical study reports and ensures compliance with the highest scientific standards.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250221805824/en/
By combining Go Reply's expertise in Google technologies with Sprint Reply’s ability to transform business models, a cutting-edge solution has been created that allows Dr. Willmar Schwabe's team to focus on what really matters: advancing research for innovative medicines to improve public health. (Graphic: Business Wire)
To obtain marketing authorisation for its high-quality herbal drugs, Dr. Willmar Schwabe must rigorously test their efficacy, safety and tolerability in clinical trials. By leveraging the power of Google Cloud and its Large Language Model (LLM) Gemini, the tool developed by Go Reply and Sprint Reply significantly simplifies the traditionally time-consuming process of creation of the final reports from these clinical trials. Using pre-defined prompts, staff no longer need to manually summarise all the results, which are often meticulously documented over 1,000 pages and can efficiently generate detailed report sections that fully comply with the International Council for Harmonisation (ICH) standards.
"Developing an AI-based solution for a medical writing task together with Reply is a milestone for us," stated Dirk Bredenbröker, Executive Vice President Research & Development at Dr. Willmar Schwabe. "By working with the experts at Go Reply and Sprint Reply, we have now developed a better understanding of the potential of AI and how it can be used profitably in different areas."
By combining Go Reply's expertise in Google technologies with Sprint Reply’s ability to transform business models, a cutting-edge solution has been created that allows Dr. Willmar Schwabe's team to focus on what really matters: advancing research for innovative medicines to improve public health.
Go Reply
Go Reply, as part of the Reply Group, is a Google Cloud Premier Partner offering services in the following areas: Cloud Strategy and Migration, Cloud Hosting, Big Data, Machine Learning, Generative AI, PCI/ISO Compliance and Security Management, Productivity Services and fully managed services around the clock that support business-critical applications. www.go-reply.com
Sprint Reply
Sprint Reply specialises in strategic consulting, innovation and digital transformation. We support large and medium-sized companies in all industries in developing new and digital business opportunities. We are your partner for your current and future digital challenges. With our implementation-oriented approach, we help our clients to become digital pioneers in their respective industries. www.sprint-reply.de
Dr. Willmar Schwabe
Dr. Willmar Schwabe is a global leader in the production and research of herbal medicinal products with over 150 years of experience. As a traditional family-owned company based in Karlsruhe, Dr. Willmar Schwabe focuses on scientific research, standardisation and continuous improvement of herbal preparations. With over 4,000 employees worldwide, including around 1,400 in Germany, the company is committed to the highest quality and innovation in phytotherapy. Dr. Willmar Schwabe products are based on patented plant extracts and clinically proven efficacy to sustainably promote people's health. www.schwabe-group.com/en
View source version on businesswire.com: https://www.businesswire.com/news/home/20250221805824/en/
Contacts
Media contact:
Reply
Fabio Zappelli
f.zappelli@reply.com
Phone +390117711594
Irene Caia
i.caia@reply.com
Tel. +39 02 535761
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alpha Blue Ocean Group Announces the Launch of its Investment Banking Service Provider Division: ABO Transaction Advisory Services. Pierre Vannineuse Steps Down as CIO of ABO’s Investment Division to Lead ABO Transaction Advisory Services Full Time21.2.2025 16:00:00 EET | Press release
ABO Group, a market leader in Europe for PIPE deals and complex public cross border M&As, announces the establishment of Alpha Blue Ocean Transaction Advisory Services LTD ("ABO-TAS"), a new division dedicated to offering Public Listing Advisory, Capital Raise Advisory, Non-Deal Roadshows, M&A, Management Consulting, Restructuring Advisory and other transaction advisory services. ABO TAS is fully segregated and separate from the Alpha Blue Ocean Group’s Investment Division (which carries out the traditional investment activities of the ABO Group). ABO Group’s investment banking services will leverage the decades of combined experience of the ABO TAS team in investment banking, Public ECM and DCM and most notably structured PIPEs and complex cross border transactions. On the consulting side, the ABO TAS team is dedicated to help businesses reach their maximum potential by capturing synergies between companies and its broad network of established relationships. To spearhead this initiati
Erectile Dysfunction: The PelviTouch Revolution Comes From DEKA’s Italian Technology21.2.2025 15:30:00 EET | Press release
DEKA Laser, a subsidiary of El.En. S.p.A., a company operating in the Laser and Energy-Based Devices market, listed on Borsa Italiana’s Euronext STAR Milan (“STAR”), and a global leader in medical technologies, has presented its latest innovative therapy, PelviTouch, for the treatment of erectile dysfunction, at the European Society for Sexual Medicine (ESSM) congress. This technology was initially developed, with great success, for the treatment of urinary incontinence for both sexes, and it has now been optimized and specialized by DEKA’s research and development team to improve men’s intimate health, with effective treatments aimed specifically at erectile dysfunction, a field in which the Italian company is an absolute pioneer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250221055364/en/ PelviTouch Therapy Presentation at ESSM Congress (Photo by DEKA) Paolo Salvadeo, DEKA’s CEO and El.En. S.p.A.’s General Manager, has
KKR Invests in Stockholm Multifamily Housing Development Led by Reliwe and Derome21.2.2025 09:10:00 EET | Press release
Global investment firm KKR today announced the agreement with leading Swedish developers Reliwe and The Derome Group for the forward-purchase of three multifamily properties currently under development in Haninge, located just south of the Stockholm city center. The investment is being made by KKR's European Real Estate strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250220298047/en/ Credit: Reliwe / Lindberg Stenberg Arkitekter AB The development is comprised of three new properties totaling 382 residential units, expected to be completed between late 2026 and early 2027. Leading Swedish property developer Reliwe is overseeing the development, which includes two timber construction properties being built by Derome, a leading industrial business, and a third traditional concrete construction asset built to a high specification. The development is located adjacent to a bus terminal and railway station, offering excel
Digital Prosperity Awards Winners Announced at 4 th General Assembly of the Digital Cooperation Organization21.2.2025 00:09:00 EET | Press release
The Digital Cooperation Organization (DCO), the world's first standalone international intergovernmental organization focusing on the acceleration of the growth of an inclusive and sustainable digital economy, has unveiled the winners of the Digital Prosperity Awards at a ceremony held at its 4th General Assembly gala dinner hosted by the Hashemite Kingdom of Jordan, in the Dead Sea. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250220587577/en/ Digital Prosperity Awards winners announced at 4th General Assembly of the Digital Cooperation Organization (Photo: AETOSWire) Attended by high-level delegations from DCO’s 16 Member States, as well as DCO’s Observers, Partners, and distinguished guests, the Awards aim to acknowledge exceptional initiatives in adopting best practices, policies, and strategies to accelerate digital transformation in their respective countries. The objective is to accelerate digital economic advanceme
IFF Announces Executive Leadership Team Aligned With New Operating Model20.2.2025 23:30:00 EET | Press release
IFF (NYSE: IFF) announced changes to its executive leadership team, aligned with the Company’s external reporting structure. After 21 years of dedicated service to IFF, Simon Herriott, president of Health and Biosciences, will step down. Effective March 1, Leticia Gonçalves, ADM’s president of precision fermentation and ADM Ventures, will join IFF as president of Health and Biosciences. “Since 2019, Simon has driven growth and operational effectiveness through innovation, customer intimacy and supply chain development as president of our Health and Biosciences business unit,” said Erik Fyrwald, IFF CEO. “We’re grateful for Simon’s tremendous contributions to IFF and wish him well for the future. His dedication and leadership will leave a lasting impact on our organization.” Gonçalves brings to IFF extensive experience with IFF’s end markets in innovation-based companies, having served in various senior global and regional P&L leadership roles at ADM, Bayer and Monsanto in Brazil, Europ
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom